NASDAQ: PCSA
Processa Pharmaceuticals Inc Stock Ownership - Who owns Processa Pharmaceuticals?

Insider buying vs selling

Have Processa Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sian BigoraChief Development Officer2025-04-013,311$0.41
$1.36kSell
Patrick LinChief Business - Strategy Off2025-04-014,814$0.41
$1.98kSell
David 1. YoungPres. Research Development2025-04-015,345$0.41
$2.20kSell

1 of 1

PCSA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PCSA insiders and whales buy or sell their stock.

PCSA Shareholders

What type of owners hold Processa Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James E. Besser64.36%1,458,300$4.58MInsider
Justin W. Yorke49.61%1,124,049$3.53MInsider
Stonepine Capital Management LLC45.47%1,030,200$3.23MInstitution
George K. Ng14.44%327,200$1.03MInsider
Geode Capital Management LLC13.39%303,304$952.37kInstitution
Vanguard Group Inc12.72%288,212$904.99kInstitution
David 1. Young12.25%277,647$871.81kInsider
Virgil Thompson10.63%240,755$755.97kInsider
Khalid Islam8.54%193,395$607.26kInsider
Robert Michael Floyd7.59%172,061$540.27kInsider

1 of 3

PCSA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PCSA30.51%69.49%Net Selling
APVO12.10%87.90%Net BuyingNet Buying
APM0.08%29.22%
GTBP3.52%11.34%
MBIO3.84%13.88%Net SellingNet Selling

Processa Pharmaceuticals Stock Ownership FAQ

Who owns Processa Pharmaceuticals?

Processa Pharmaceuticals (NASDAQ: PCSA) is owned by 78.60% institutional shareholders, 179.06% Processa Pharmaceuticals insiders, and 0.00% retail investors. James E. Besser is the largest individual Processa Pharmaceuticals shareholder, owning 1.46M shares representing 64.36% of the company. James E. Besser's Processa Pharmaceuticals shares are currently valued at $4.37M.

If you're new to stock investing, here's how to buy Processa Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.